The Speakers/Moderators
Saturday October 16, 2021
(Sessions 4, 5, 6)
Session 4 (10:00am-11:55 am CST, Saturday Oct 16)
Scriptors : RNA localization, efflux and metabolism in heart
Moderators
Srikanth Garikipati, PhD
The Ohio State University
Columbus, USA
10:00-10:20 am CST
Circular RNAs as novel therapeutic targets for cardiovascular disease
Anna University
Chennai, India
10:20-10:40 am CST
Emerging role of LncRNAs in Diabetic cardiomyopathy
Technion-Israel Institute of Technology
Israel
10:40-11:00 am CST
Spatiotemporal maintenance of sarcomeric RNA and proteins
Indiana University
Indianapolis, USA
11:00-11:20 am CST
β-arrestin-mediated β-adrenergic receptor signaling and microRNA biogenesis in heart failure
Kansas City University
Kansas City, USA
11:20-11:40 am CST
Noncoding scaRNAs influence alternative splicing of mRNA and heart development
Trainee presentation
Vinoth Sigamani, M.Tech
The University of Tennessee Health Science Center
Memphis, USA
11:40-11:55 am CST
Beneficial Effect of scaRNA20 in iPSC-derived Cardiomyocytes under Hypoxic Environment
Break
Session 5 (12:00pm-1:20 pm CST, Saturday Oct 16)
Residents : Fibroblasts and endothelial cells, role and contribution in cardiac pathophysiology
Moderators
University of Strathclyde
Glasgow, UK
12:00-12:20 pm CST
Cardiotoxicity and the cardiac fibroblast
The University of Illinois at Chicago
Chicago, USA
12:20-12:40 pm CST
The Role of KLF4 in Idiopathic Pulmonary Fibrosis
The University of Chicago
Chicago, USA
12:40-1:00 pm CST
HIF1/ARNT is a novel regulator of cardiac homeostasis and disease
Universite De Sherbrooke,
Quebec, Canada
1:00-1:20 pm CST
Targeting the apelinergic system in cardiovascular diseases
Break
Session 6 (1:30pm-3:20 pm CST, Saturday Oct 16)
Imitators : Stem cells in cardiovascular regeneration and therapeutics
Moderators
Augusta University
Augusta, USA
1:30-1:50 pm CST
Notch responsive H19X regulates neovascularization via HIF-1α Signaling
Stanford University
Stanford, USA
1:50-2:10 pm CST
Identifying Therapeutic Drugs using iPSCs for LMNA associated cardiomyopathy
Narasimman Gurusamy, PhD
The University of Tennessee Health Science Center
Memphis, USA
2:10-2:30 pm CST
Non-invasively derived human induced-mesenchymal stem cells from urinary epithelial cells for regenerative therapy
Trainee presentation
Sarojini Singh, PhD
The University of Alabama at Birmingham,
Alabama, USA
2:30-2:50 pm CST
Effects of Depression on Cardiac Pathophysiology
Trainee presentation
Abhay Srivastava
St-Boniface Hospital Research
Winnipeg, Canada
2:50-3:05 pm CST
Induced pluripotent stem cell-based clinical trial selection platform for patients with in-born metabolic disorders
Weiang Yan
Weiang Yan
St-Boniface Hospital Research
Winnipeg, Canada
3:05-3:20 pm CST